Participant characteristics and clinical trial decision-making factors in AIDS malignancy consortium treatment trials for HIV-infected persons with cancer (AMC #S006).

ABSTRACT:

Background

Overall, people living with HIV/AIDS (PLWHA) are living longer, but compared with the general population, they are at elevated risk for numerous AIDS-defining and non-AIDS-defining cancers. The AIDS Malignancy Consortium (AMC) is dedicated to conducting clinical trials aimed at prevention and treatment of cancers among PLWHA.

Objective

To examine patient-level characteristics and perceptions that influence decision-making regarding AMC treatment trial participation.

Methods

PLWHA diagnosed with cancer or anal high-grade intraepithelial neoplasia who were ≥18 years old and offered participation on a therapeutic AMC clinical trial were eligible. Participants completed a 17-item survey assessing sociodemographic and other factors potentially influencing decisi

SUBMITTER: Burkhalter JE 

PROVIDER: S-EPMC6428211 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature